meta-analysis | Q815382 |
scholarly article | Q13442814 |
P356 | DOI | 10.1002/14651858.CD006362.PUB2 |
P698 | PubMed publication ID | 19588387 |
P2093 | author name string | Hye Min Cho | |
Yoo Sun Moon | |||
Yoon-Jung Chang | |||
Soo young Kim | |||
Ye-won Hwang | |||
P2860 | cites work | Acetaminophen (paracetamol) for the common cold in adults | Q24236805 |
Intranasal ipratropium bromide for the common cold | Q24241392 | ||
Oral antihistamine-decongestant-analgesic combinations for the common cold | Q24242520 | ||
Nasal decongestants for the common cold | Q24246461 | ||
Antihistamines for the common cold | Q24247974 | ||
Effects of acetylsalicylic acid on sore throat pain and other pain symptoms associated with acute upper respiratory tract infection | Q28196807 | ||
Understanding the symptoms of the common cold and influenza | Q28279275 | ||
Viral respiratory infection therapy: historical perspectives and current trials | Q30309230 | ||
Effects of naproxen on experimental rhinovirus colds. A randomized, double-blind, controlled trial | Q30311270 | ||
??? | Q28191745 | ||
Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s | Q33974678 | ||
Increased Virus Shedding With Aspirin Treatment of Rhinovirus Infection | Q33992687 | ||
The diagnosis and treatment of cough | Q34098934 | ||
The common cold | Q34169126 | ||
Cough and the common cold: ACCP evidence-based clinical practice guidelines | Q34486891 | ||
Influence of loxoprofen use on recovery from naturally acquired upper respiratory tract infections: a randomized controlled trial | Q34581619 | ||
Lowest effective single dose of diclofenac for antipyretic and analgesic effects in acute febrile sore throat | Q39334823 | ||
Demonstration of dose response of flurbiprofen lozenges with the sore throat pain model | Q39407101 | ||
Efficacy and Tolerability of the Anti-inflammatory Throat Lozenge Flurbiprofen 8.75mg in the Treatment of Sore Throat : A Randomised, Double-Blind, Placebo-Controlled Study | Q39421515 | ||
A placebo-controlled model for assaying systemic analgesics in children | Q39493911 | ||
Nimesulide granules for the treatment of acute inflammation of the ear, nose or throat | Q39497868 | ||
Therapeutic Utility of NAPROXEN on Acute Upper Respiratory Infection-Multi-Clinical Double Blind Study | Q39629220 | ||
Antipyretic and Analgesic Effects of Zaltoprofen for the Treatment of Acute Upper Respiratory Tract Infection: Verification of a Noninferiority Hypothesis Using Loxoprofen Sodium | Q40330094 | ||
A double-blind study of zaltoprofen for the treatment of upper respiratory tract infection | Q40370854 | ||
Assessment of the efficacy and safety of paracetamol, ibuprofen and nimesulide in children with upper respiratory tract infections | Q40627404 | ||
Antipyretic efficacy of tiaprofenic acid in febrile children | Q40674420 | ||
Efficacy and tolerability of nimesulide and lysine-acetylsalicylate in the treatment of paediatric acute upper respiratory tract inflammation. | Q40725593 | ||
Adverse effects of aspirin, acetaminophen, and ibuprofen on immune function, viral shedding, and clinical status in rhinovirus-infected volunteers | Q40755914 | ||
A multi-centre, double-blind randomized study to assess the efficacy and tolerance of sulindac versus placebo in the symptomatic treatment of patients with upper respiratory tract infection | Q40821529 | ||
Comparative evaluation of antipyretic activity of ibuprofen and aspirin in children with pyrexia of varied aetiology | Q40830590 | ||
Therapeutic effects of fenbufen in common cold--multi-clinic double blind study | Q41296837 | ||
Risk of cardiovascular events and rofecoxib: cumulative meta-analysis | Q45175627 | ||
[A double-blind clinical evaluation of suprofen on acute upper respiratory infection. Comparison with aspirin] | Q70434710 | ||
[Clinical evaluation of sulindac (CLINORIL) in the treatment of acute upper respiratory tract infection--double-blind comparison with ibuprofen] | Q70448900 | ||
[Clinical evaluation of oxaprozin in the treatment of acute upper respiratory tract inflammations--a double-blind comparative study using ibuprofen as the control drug] | Q70511047 | ||
[A double-blind clinical evaluation of flurbiprofen on acute upper respiratory tract inflammation--comparative study with ibuprofen] | Q70518407 | ||
Double-blind study of nimesulide in divers with inflammatory disorders of the ear, nose and throat | Q71604951 | ||
Treatment of upper airways inflammation with nimesulide | Q71604954 | ||
A double-blind comparison of nimesulide and mefenamic acid in the treatment of acute upper respiratory tract infections in children | Q71605004 | ||
[Double blind controlled study of miroprofen in acute upper respiratory tract infections--comparison with ibuprofen] | Q71620284 | ||
[Clinical evaluation of Clinoril tablets in acute upper respiratory tract infections] | Q71645588 | ||
Nimesulide and antibiotics in the treatment of acute infections of the respiratory tract | Q93854462 | ||
P921 | main subject | common cold | Q12125 |
inflammation | Q101991 | ||
P577 | publication date | 2009-07-08 | |
P13046 | publication type of scholarly work | review article | Q7318358 |
P1433 | published in | Cochrane Database of Systematic Reviews | Q15750361 |
P1476 | title | Non-steroidal anti-inflammatory drugs for the common cold |
Q34886569 | A Comparison of the Efficacy and Safety of Non-Steroidal Anti-Inflammatory Drugs versus Acetaminophen in Symptom Relief for the Common Cold: A Meta-Analysis of Randomized Controlled Trial Studies |
Q35021448 | A crossover randomized comparative study of zofenopril and ramipril on cough reflex and airway inflammation in healthy volunteers |
Q24201410 | Acetaminophen (paracetamol) for the common cold in adults |
Q24236805 | Acetaminophen (paracetamol) for the common cold in adults |
Q39391217 | Attenuation of prostaglandin E2 elimination across the mouse blood-brain barrier in lipopolysaccharide-induced inflammation and additive inhibitory effect of cefmetazole |
Q24634552 | Complementary and alternative medicine for prevention and treatment of the common cold |
Q38114302 | Complementary and integrative treatments: upper respiratory infection |
Q37343058 | Efficacy of a carrageenan nasal spray in patients with common cold: a randomized controlled trial |
Q34656522 | Efficacy of anti-inflammatory or antibiotic treatment in patients with non-complicated acute bronchitis and discoloured sputum: randomised placebo controlled trial |
Q51593314 | Evaluation of the prescriptions written for upper respiratory tract infections |
Q51563081 | Guideline on the investigation and management of acute transfusion reactions Prepared by the BCSH Blood Transfusion Task Force |
Q24201895 | Intranasal ipratropium bromide for the common cold |
Q24235444 | Intranasal ipratropium bromide for the common cold |
Q45916948 | Le traitement de la toux et du rhume : des conseils pour ceux qui s’occupent d’enfants et d’adolescents. |
Q36076845 | Non-steroidal Anti-inflammatory Drugs (NSAIDs) Use in Primary Health Care Centers in A'Seeb, Muscat: A Clinical Audit |
Q24187086 | Non-steroidal anti-inflammatory drugs for the common cold |
Q24202284 | Non-steroidal anti-inflammatory drugs for the common cold |
Q33646392 | Patient presentation and physician management of upper respiratory tract infections: a retrospective review of over 5 million primary clinic consultations in Hong Kong |
Q24282600 | Prevention and treatment of the common cold: making sense of the evidence |
Q35363956 | Public health and budget impact of probiotics on common respiratory tract infections: a modelling study |
Q34350110 | Reducing uncertainty in managing respiratory tract infections in primary care |
Q35572634 | Treating cough and cold: Guidance for caregivers of children and youth |
Q92029807 | Treatment of signs and symptoms of the common cold using EPs 7630 - results of a meta-analysis |
Q48157501 | VEGF receptor-1 involvement in pericyte loss induced by Escherichia coli in an in vitro model of blood brain barrier. |
Search more.